Literature DB >> 17868806

Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.

Alfred E Buxton1, Kerry L Lee, Gail E Hafley, Luis A Pires, John D Fisher, Michael R Gold, Mark E Josephson, Michael H Lehmann, Eric N Prystowsky.   

Abstract

OBJECTIVES: We determined the contribution of multiple variables to predict arrhythmic death and total mortality risk in patients with coronary disease and left ventricular dysfunction. We then constructed an algorithm to predict risk of mortality and sudden death.
BACKGROUND: Many factors in addition to ejection fraction (EF) influence the prognosis of patients with coronary disease. However, there are few tools to use this information to guide clinical decisions.
METHODS: We evaluated the relationship between 25 variables and total mortality and arrhythmic death in 674 patients enrolled in the MUSTT (Multicenter Unsustained Tachycardia Trial) study that did not receive antiarrhythmic therapy. We then constructed risk-stratification algorithms to weight the prognostic impact of each variable on arrhythmic death and total mortality risk.
RESULTS: The variables having the greatest prognostic impact in multivariable analysis were functional class, history of heart failure, nonsustained ventricular tachycardia not related to bypass surgery, EF, age, left ventricular conduction abnormalities, inducible sustained ventricular tachycardia, enrollment as an inpatient, and atrial fibrillation. The model demonstrates that patients whose only risk factor is EF < or =30% have a predicted 2-year arrhythmic death risk <5%.
CONCLUSIONS: Multiple variables influence arrhythmic death and total mortality risk. Patients with EF < or =30% but no other risk factor have low predicted mortality risk. Patients with EF >30% and other risk factors may have higher mortality and a higher risk of sudden death than some patients with EF < or =30%. Thus, risk of sudden death in patients with coronary disease depends on multiple variables in addition to EF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17868806     DOI: 10.1016/j.jacc.2007.04.095

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  109 in total

Review 1.  Radionuclide imaging of cardiac autonomic innervation.

Authors:  Sang Yong Ji; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

2.  A rose by any other name.

Authors:  Timothy F Christian
Journal:  J Nucl Cardiol       Date:  2015-10-30       Impact factor: 5.952

3.  Predicting cardiac events using ventricular dyssynchrony in patients who received implantable cardioverter defibrillators: Are more treatment options required?

Authors:  Keiichiro Yoshinaga
Journal:  J Nucl Cardiol       Date:  2015-11-24       Impact factor: 5.952

4.  Myocardial denervation coincides with scar heterogeneity in ischemic cardiomyopathy: A PET and CMR study.

Authors:  Stefan de Haan; Mischa T Rijnierse; Hendrik J Harms; Hein J Verberne; Adriaan A Lammertsma; Marc C Huisman; Albert D Windhorst; Albert C van Rossum; Cornelis P Allaart; Paul Knaapen
Journal:  J Nucl Cardiol       Date:  2015-11-09       Impact factor: 5.952

Review 5.  The 12-lead electrocardiogram and risk of sudden death: current utility and future prospects.

Authors:  Kumar Narayanan; Sumeet S Chugh
Journal:  Europace       Date:  2015-10       Impact factor: 5.214

6.  Use and Abuse of Internal Cardioverter Defibrillators for Primary Prevention.

Authors:  Joshua R Silverstein; Demosthenes G Katritsis; Mark E Josephson
Journal:  Arrhythm Electrophysiol Rev       Date:  2012-09

Review 7.  The role of radionuclide imaging in heart failure.

Authors:  Vinay Gulati; Gilbert Ching; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

8.  Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.

Authors:  Selcuk Adabag; Kristen K Patton; Alfred E Buxton; Thomas S Rector; Kristine E Ensrud; Kairav Vakil; Wayne C Levy; Jeanne E Poole
Journal:  JAMA Cardiol       Date:  2017-07-01       Impact factor: 14.676

9.  Improving sudden cardiac death risk stratification by evaluating electrocardiographic measures of global electrical heterogeneity and clinical outcomes among patients with implantable cardioverter-defibrillators: rationale and design for a retrospective, multicenter, cohort study.

Authors:  Jonathan W Waks; Christopher Hamilton; Saumya Das; Ashkan Ehdaie; Jessica Minnier; Sanjiv Narayan; Mark Niebauer; Merritt Raitt; Christine Tompkins; Niraj Varma; Sumeet Chugh; Larisa G Tereshchenko
Journal:  J Interv Card Electrophysiol       Date:  2018-03-14       Impact factor: 1.900

Review 10.  A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification.

Authors:  Faisal M Merchant; Hui Zheng; Thomas Bigger; Richard Steinman; Takanori Ikeda; Roberto F E Pedretti; Jorge A Salerno-Uriarte; Catherine Klersy; Paul S Chan; Cheryl Bartone; Stefan H Hohnloser; Jeremy N Ruskin; Antonis A Armoundas
Journal:  Am Heart J       Date:  2013-09-18       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.